CD4 and cardiovascular disorder: In contrast, the risk of recurrence of cardiovascular disease remained low for the patients with low (<1%) CD4+CD28null T-cell levels regardless of statin use, indicating that statins provided limited cardiovascular benefits to these patients (3).